
Salarius Pharmaceuticals Inc. Raises $3.8 Million Through Issuance of 5.5 Million Shares Under Equity Line of Credit

I'm PortAI, I can summarize articles.
Salarius Pharmaceuticals Inc. raised approximately $3.8 million by issuing 5.5 million shares of common stock under an equity line of credit. The transactions took place between July 10 and July 30, 2025, as part of a Securities Purchase Agreement with C/M Capital Master Fund, LP. The original content was published via EDGAR on July 31, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

